Insider Transactions in Q1 2024 at Alignment Healthcare, Inc. (ALHC)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 28
2024
|
Hakan Kardes Chief Experience Officer |
SELL
Open market or private sale
|
Direct |
4,363
-1.0%
|
$17,452
$4.84 P/Share
|
|
Mar 28
2024
|
Robert Thomas Freeman Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
4,299
-0.49%
|
$17,196
$4.84 P/Share
|
|
Mar 28
2024
|
Dawn Christine Maroney President, Markets |
SELL
Open market or private sale
|
Direct |
10,151
-0.51%
|
$40,604
$4.84 P/Share
|
|
Mar 28
2024
|
Robert L. Scavo Chief Information Officer |
SELL
Open market or private sale
|
Direct |
1,821
-0.42%
|
$7,284
$4.84 P/Share
|
|
Mar 20
2024
|
Dawn Christine Maroney President, Markets |
SELL
Open market or private sale
|
Direct |
13,252
-0.66%
|
$53,008
$4.83 P/Share
|
|
Mar 19
2024
|
Robert Thomas Freeman Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
28,522
-3.18%
|
$142,610
$5.05 P/Share
|
|
Mar 19
2024
|
Hakan Kardes Chief Experience Officer |
SELL
Open market or private sale
|
Direct |
18,964
-4.18%
|
$94,820
$5.05 P/Share
|
|
Mar 19
2024
|
Hyong Kim Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,576
-0.99%
|
$27,880
$5.05 P/Share
|
|
Mar 19
2024
|
Christopher J Joyce Chief Legal and Admin. Officer |
SELL
Open market or private sale
|
Direct |
25,060
-5.4%
|
$125,300
$5.05 P/Share
|
|
Mar 19
2024
|
Robert L. Scavo Chief Information Officer |
SELL
Open market or private sale
|
Direct |
3,078
-0.7%
|
$15,390
$5.05 P/Share
|
|
Mar 19
2024
|
Dawn Christine Maroney President, Markets |
SELL
Open market or private sale
|
Direct |
15,861
-0.79%
|
$79,305
$5.05 P/Share
|
|
Mar 15
2024
|
Hakan Kardes Chief Experience Officer |
SELL
Open market or private sale
|
Direct |
4,326
-0.94%
|
$17,304
$4.89 P/Share
|
|
Mar 15
2024
|
Robert Thomas Freeman Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
11,858
-1.3%
|
$47,432
$4.89 P/Share
|
|
Mar 15
2024
|
Dawn Christine Maroney President, Markets |
SELL
Open market or private sale
|
Direct |
21,537
-1.06%
|
$86,148
$4.89 P/Share
|
|
Mar 15
2024
|
Robert L. Scavo Chief Information Officer |
SELL
Open market or private sale
|
Direct |
4,852
-1.09%
|
$19,408
$4.89 P/Share
|
|
Mar 14
2024
|
John E Kao Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
103,000
+3.62%
|
$412,000
$4.82 P/Share
|
|
Mar 13
2024
|
General Atlantic LLC Director |
BUY
Grant, award, or other acquisition
|
Indirect |
100,000
+0.16%
|
-
|
|
Mar 13
2024
|
General Atlantic (Aln Hlth), L.P. Director |
BUY
Grant, award, or other acquisition
|
Indirect |
100,000
+0.16%
|
-
|
|
Mar 13
2024
|
Sebastian Burzacchi COO - Mgmt Services Org |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+30.68%
|
-
|
|
Mar 13
2024
|
David C Hodgson Director |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+26.92%
|
-
|
|
Mar 13
2024
|
Hakan Kardes Chief Experience Officer |
BUY
Grant, award, or other acquisition
|
Direct |
140,190
+23.43%
|
-
|
|
Mar 13
2024
|
Joseph S Konowiecki Director |
BUY
Grant, award, or other acquisition
|
Direct |
70,000
+5.27%
|
-
|
|
Mar 13
2024
|
Robert Thomas Freeman Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
200,710
+18.07%
|
-
|
|
Mar 13
2024
|
Christopher J Joyce Chief Legal and Admin. Officer |
BUY
Grant, award, or other acquisition
|
Direct |
196,138
+29.71%
|
-
|
|
Mar 13
2024
|
Nicholas Robbert Vorhoff Director |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+26.92%
|
-
|
|
Mar 13
2024
|
Thomas J. Carella Director |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+24.32%
|
-
|
|
Mar 13
2024
|
Dawn Christine Maroney President, Markets |
BUY
Grant, award, or other acquisition
|
Direct |
206,890
+9.22%
|
-
|
|
Mar 13
2024
|
Jody L Bilney Director |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+29.04%
|
-
|
|
Mar 13
2024
|
Mark B. Mc Clellan Director |
BUY
Grant, award, or other acquisition
|
Direct |
30,000
+8.0%
|
-
|
|
Mar 13
2024
|
Jacqueline B Kosecoff Director |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+12.55%
|
-
|
|
Mar 13
2024
|
Andreas P. Wagner Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
60,000
+21.76%
|
-
|
|
Mar 13
2024
|
John E Kao Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
330,000
+11.1%
|
-
|
|
Mar 13
2024
|
Yon Jorden Director |
BUY
Grant, award, or other acquisition
|
Direct |
30,000
+27.16%
|
-
|
|
Mar 13
2024
|
Robert L. Scavo Chief Information Officer |
BUY
Grant, award, or other acquisition
|
Direct |
80,000
+15.19%
|
-
|
|
Mar 13
2024
|
Hyong Kim Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
158,970
+22.08%
|
-
|
|
Mar 13
2024
|
Margaret M Mc Carthy Director |
BUY
Grant, award, or other acquisition
|
Direct |
33,500
+22.32%
|
-
|
|
Mar 13
2024
|
Jeffrey H Margolis Director |
BUY
Grant, award, or other acquisition
|
Direct |
30,000
+22.31%
|
-
|
|
Mar 08
2024
|
John E Kao Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
34,520
-1.47%
|
$172,600
$5.39 P/Share
|
|
Mar 08
2024
|
Dawn Christine Maroney President, Markets |
SELL
Open market or private sale
|
Direct |
23,000
-1.24%
|
$115,000
$5.44 P/Share
|
|
Mar 06
2024
|
Dawn Christine Maroney President, Markets |
SELL
Bona fide gift
|
Direct |
6,000
-0.32%
|
-
|
|
Feb 07
2024
|
Andreas P. Wagner Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
155,763
+50.0%
|
-
|